Observation of Clozapine Treatment Safety in Bipolar Disorder. - Trial NCT06011460
Access comprehensive clinical trial information for NCT06011460 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical University of Gdansk and is currently Enrolling by invitation. The study focuses on Bipolar Disorder. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Medical University of Gdansk
Timeline & Enrollment
N/A
Feb 23, 2023
Jun 30, 2027
Primary Outcome
Safety measures of clozapine treatment in patients with bipolar disorder.
Summary
The purpose of the registry is to record incidence of adverse events during treatment with
 clozapine in patients suffering from bipolar disorder.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06011460
Non-Device Trial